PADLOCK PARTNERS UK FUND I ANNOUNCES DISTRIBUTIONS FOR 4th QUARTER OF CALENDAR YEAR 2023
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
TORONTO, Jan. 10, 2024 /CNW/ - Padlock Partners UK Fund I (the "Trust") announced today that its Board of Trustees has declared a cash distribution for the fourth quarter of the calendar year of 2023. The distribution will be payable on January 15, 2024, to unitholders of record as of the close of business on December 31, 2023. The distribution amounts will be as follows:
C$0. 15116 per Class A Unit
C$0. 15598 per Class F Unit
GBP$0. 15522 per Class U Unit
About Padlock Partners UK Fund I
The Trust is an unincorporated investment trust and was established for the primary purpose of investing in a diversified portfolio of income producing commercial real estate properties in the United Kingdom with a focus on self-storage and mixed-use properties. Currently, the Trust has acquired self-storage properties in Bicester, Letchworth, Leighton Buzzard, Wimbledon, Chippenham and Enfield.
Airbus Canada Limited Partnership (Airbus Canada) is pleased to announce that it has reached a labour agreement with the 1,300 unionized employees at its Mirabel site, in Quebec. After several months of negotiations, the employees who assemble the...
Caribbean Utilities Company, Ltd. ("CUC or "the Company") announced its consolidated unaudited results for the three months ended March 31, 2024 ("First Quarter 2024" or "Q1 2024") (all figures stated in United States Dollars)....
Pangea Entertainment Productions (Venice, Ca.) and Big Bang Mediaverse (Mumbai, India) announce a partnership to create and produce innovative multiplatform content aimed at younger and connected audiences globally and in India. The first program in...
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Akero Therapeutics, Inc. ("Akero" or "the Company") and certain of its officers....
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc. today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and Poseida have entered into a...
L&F Brown, P.C., a law firm serving the needs of Fintech, Legaltech and other innovative companies, has announced the addition of?Fred Ghodoosi?as Senior Litigation Counsel. Throughout his career, Ghodoosi has been counsel for Fortune 100 companies,...
